Want to see DWTX full AI Analyst Report?
Dogwood Therapeutics (DWTX) Income Statement
Dogwood Therapeutics Income Statement
Last quarter (Q2 2026), Dogwood Therapeutics's total revenue was $0.00. In Q2, Dogwood Therapeutics's net income was $-11.53M. See Dogwood Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ -12.18K | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 27.97M | $ 12.23M | $ 5.45M | $ 12.32M | $ 15.64M | |
| Depreciation and Amortization | $ 2.06K | $ 12.18K | $ 0.00 | $ 0.00 | $ 0.00 |
| $ -34.03M | $ -12.25M | $ -5.30M | $ -12.25M | $ -15.96M | |
| $ -27.97M | $ -12.23M | $ -5.45M | $ -12.32M | $ -15.64M | |
| $ -6.07M | $ -122.98K | $ 150.90K | $ 67.47K | $ -319.33K | |
| $ -34.04M | $ -12.35M | $ -5.30M | $ -12.25M | $ -15.96M | |
| $ -34.26M | $ -12.35M | $ -5.30M | $ -12.25M | $ -15.96M | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.32 | $ -12.52 | $ -7.05 | $ -27.66 | $ -47.90 |
| Diluted EPS | $ -4.32 | $ -12.52 | $ -7.05 | $ -27.66 | $ -47.90 |
| Weighted Average Shares Outstanding | 8.22M | 1.03M | 751.07K | 442.80K | 333.17K |
| Weighted Average Shares Outstanding (Diluted) | 8.22M | 1.03M | 751.07K | 442.80K | 333.17K |
Currency in USD
